Identification Generic Name (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE DrugBank Accession Number DB07026 Background Not Available Type Small Molecule Groups Experimental Structure 
 
 
 3D Download  MOL SDF 3D-SDF PDB SMILES InChI 
 
 
  Similar Structures Structure for (1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE (DB07026) ×  Close Weight Average: 383.3978  Monoisotopic: 383.148120797  Chemical Formula C 20 H 21 N 3 O 5 Synonyms Not Available Pharmacology Indication Not Available Reduce drug development failure rates Build, train, & validate machine-learning models with evidence-based and structured datasets. See how     Build, train, & validate predictive machine-learning models with structured datasets. See how Contraindications & Blackbox Warnings Avoid life-threatening adverse drug events Improve clinical decision support with information on  contraindications & blackbox warnings, population restrictions, harmful risks, & more. Learn more     Avoid life-threatening adverse drug events & improve clinical decision support. Learn more Pharmacodynamics Not Available Mechanism of action Target Actions Organism U Macrophage metalloelastase Not Available Humans Absorption Not Available Volume of distribution Not Available Protein binding Not Available Metabolism Not Available Route of elimination Not Available Half-life Not Available Clearance Not Available Adverse Effects Improve decision support & research outcomes With structured adverse effects data, including:  blackbox warnings, adverse reactions, warning & precautions, & incidence rates. Learn more     Improve decision support & research outcomes with our structured adverse effects data. Learn more Toxicity Not Available Pathways Not Available Pharmacogenomic Effects/ADRs  
 
 
 Not Available Interactions Drug Interactions  
 
 
 This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.  Not Available Food Interactions Not Available Categories Drug Categories Not Available Chemical Taxonomy Provided by  Classyfire Description This compound belongs to the class of organic compounds known as biphenyls and derivatives. These are organic compounds containing to benzene rings linked together by a C-C bond. Kingdom Organic compounds Super Class Benzenoids Class Benzene and substituted derivatives Sub Class Biphenyls and derivatives Direct Parent Biphenyls and derivatives Alternative Parents Morpholine carboxylic acids and derivatives  /  1,4-oxazepines  /  1,3-dioxolanes  /  Secondary carboxylic acid amides  /  Organic carbonic acids and derivatives  /  Oxacyclic compounds  /  Azacyclic compounds  /  Acetals  /  Organopnictogen compounds  /  Organonitrogen compounds  /  Organic oxides  /  Hydrocarbon derivatives  /  Carbonyl compounds 
 
 
  show 3 more Substituents Acetal  /  Aromatic heteropolycyclic compound  /  Azacycle  /  Biphenyl  /  Carbonic acid derivative  /  Carbonyl group  /  Carboxamide group  /  Carboxylic acid derivative  /  Hydrocarbon derivative  /  Meta-dioxolane  /  Morpholine  /  Morpholine-4-carboxylic acid or derivatives  /  Organic nitrogen compound  /  Organic oxide  /  Organic oxygen compound  /  Organoheterocyclic compound  /  Organonitrogen compound  /  Organooxygen compound  /  Organopnictogen compound  /  Oxacycle  /  Oxazinane  /  Para-oxazepine  /  Secondary carboxylic acid amide 
 
 
  show 13 more Molecular Framework Aromatic heteropolycyclic compounds External Descriptors Not Available Affected organisms Not Available Chemical Identifiers UNII Not Available CAS number Not Available InChI Key PPLDARNGJSQINK-OKZBNKHCSA-N InChI InChI=1S/C20H21N3O5/c24-19(18-16-11-23(20(25)22-26)12-17(27-16)28-18)21-10-13-6-8-15(9-7-13)14-4-2-1-3-5-14/h1-9,16-18,26H,10-12H2,(H,21,24)(H,22,25)/t16-,17-,18+/m0/s1 IUPAC Name (1S,5S,7R)-N7-({[1,1'-biphenyl]-4-yl}methyl)-N3-hydroxy-6,8-dioxa-3-azabicyclo[3.2.1]octane-3,7-dicarboxamide SMILES [H][C@]12CN(C[C@]([H])(O1)[C@@]([H])(O2)C(=O)NCC1=CC=C(C=C1)C1=CC=CC=C1)C(=O)NO References General References Not Available External Links PubChem Compound 11987860 PubChem Substance 99443497 ChemSpider 10160333 BindingDB 29018 ZINC ZINC000053683784 PDBe Ligand 37A PDB Entries 2hu6 Clinical Trials Clinical Trials  
 
 
 Phase Status Purpose Conditions Count Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage Forms Not Available Prices Not Available Patents Not Available Properties State Solid Experimental Properties Not Available Predicted Properties Property Value Source Water Solubility 0.458 mg/mL ALOGPS logP 1.34 ALOGPS logP 1.51 Chemaxon logS -2.9 ALOGPS pKa (Strongest Acidic) 10.04 Chemaxon pKa (Strongest Basic) -4.1 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 5 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 100.13 Å 2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 99.56 m 3 ·mol -1 Chemaxon Polarizability 39.77 Å 3 Chemaxon Number of Rings 4 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon Predicted ADMET Features Property Value Probability Human Intestinal Absorption + 0.9709 Blood Brain Barrier + 0.8417 Caco-2 permeable - 0.6685 P-glycoprotein substrate Non-substrate 0.5548 P-glycoprotein inhibitor I Non-inhibitor 0.7543 P-glycoprotein inhibitor II Non-inhibitor 0.9602 Renal organic cation transporter Non-inhibitor 0.8647 CYP450 2C9 substrate Non-substrate 0.8304 CYP450 2D6 substrate Non-substrate 0.8136 CYP450 3A4 substrate Non-substrate 0.5622 CYP450 1A2 substrate Non-inhibitor 0.8043 CYP450 2C9 inhibitor Non-inhibitor 0.748 CYP450 2D6 inhibitor Non-inhibitor 0.8618 CYP450 2C19 inhibitor Non-inhibitor 0.6286 CYP450 3A4 inhibitor Non-inhibitor 0.7907 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.8539 Ames test AMES toxic 0.5515 Carcinogenicity Non-carcinogens 0.7753 Biodegradation Not ready biodegradable 0.5076 Rat acute toxicity 2.5093 LD50, mol/kg  Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9103 hERG inhibition (predictor II) Non-inhibitor 0.6299    ADMET data is predicted using  admetSAR , a free tool for evaluating chemical ADMET properties. ( 23092397 )  Spectra Mass Spec (NIST) Not Available Spectra Spectrum Spectrum Type Splash Key Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS Not Available Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS Not Available Targets Build, predict & validate machine-learning models Use our structured and evidence-based datasets to  unlock newinsights and accelerate drug research. Learn more     Use our structured and evidence-based datasets to unlock new insights and accelerate drug research. Learn more 
 
 
  Details 1.  Macrophage metalloelastase Kind Protein Organism Humans Pharmacological action Unknown General Function Zinc ion binding Specific Function May be involved in tissue injury and remodeling. Has significant elastolytic activity. Can accept large and small amino acids at the P1' site, but has a preference for leucine. Aromatic or hydropho... Gene Name MMP12 Uniprot ID P39900 Uniprot Name Macrophage metalloelastase Molecular Weight 54001.175 Da References Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [ Article ]  × Identify potential medication risks Easily compare up to 40 drugs with our drug interaction checker. Get severity rating, description, and management advice.  Learn more      Drug created at September 15, 2010 21:18 / Updated at June 12, 2020 16:52 